Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells
Open Access
- 1 April 2019
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 188, 103-110
Abstract
No abstract availableKeywords
Funding Information
- Flemish Research Foundation (11Y5915N, 11Y6716N)
- FWO krediet aan navorser
- Boehringer Ingelheim Fund
- KU Leuven (GOA2014/10)
This publication has 38 references indexed in Scilit:
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cellsNature Medicine, 2013
- Transfer of Regulatory Properties from Tolerogenic to Proinflammatory Dendritic Cells via Induced Autoreactive Regulatory T CellsThe Journal of Immunology, 2011
- Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancyNucleic Acids Research, 2011
- Comparative study of clinical grade human tolerogenic dendritic cellsJournal of Translational Medicine, 2011
- Role of dendritic cells in the induction of regulatory T cellsCell & Bioscience, 2011
- Connecting the mechanisms of T‐cell regulation: dendritic cells as the missing linkImmunological Reviews, 2010
- Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin DProteomics, 2009
- 1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype,The Journal of Immunology, 2009
- Pathophysiology of Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology, 2003